AG
ABMD

Advisor Group’s Abiomed Inc ABMD Stock Holding History

Advisor Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$138K Sell
813
-2,308
-74% -$428K ﹤0.01% 2690
2019
Q3 		$556K Sell
3,121
-1,338
-30% -$289K ﹤0.01% 1537
2019
Q2 		$1.16M Sell
4,459
-2,496
-36% -$662K 0.01% 1034
2019
Q1 		$1.99M Buy
6,955
+270
+4% +$89.7K 0.02% 726
2018
Q4 		$2.17M Sell
6,685
-1,363
-17% -$473K 0.02% 603
2018
Q3 		$3.62M Buy
8,048
+3,113
+63% +$1.23M 0.04% 431
2018
Q2 		$2.02M Sell
4,935
-1,480
-23% -$536K 0.03% 545
2018
Q1 		$1.87M Buy
6,415
+1,153
+22% +$292K 0.03% 581
2017
Q4 		$985K Buy
5,262
+1,505
+40% +$281K 0.01% 895
2017
Q3 		$633K Sell
3,757
-290
-7% -$43.9K 0.01% 1062
2017
Q2 		$579K Buy
4,047
+2,811
+227% +$378K 0.01% 1056
2017
Q1 		$155K Buy
1,236
+407
+49% +$47.2K ﹤0.01% 1845
2016
Q4 		$93K Sell
829
-995
-55% -$115K ﹤0.01% 2119
2016
Q3 		$234K Sell
1,824
-61
-3% -$7.31K 0.01% 1420
2016
Q2 		$204K Buy
+1,885
New +$188K 0.01% 1449

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Advisor Group's ABMD Position: Q4 2019 in Review

Advisor Group reduced its Abiomed Inc (ABMD) stake by 74% in Q4 2019, selling an estimated $428K and leaving 813 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2690.

Advisor Group first reported a position in ABMD in Q2 2016 and has held it in 15 quarters since. The position peaked at $3.62M in Q3 2018. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Advisor Group held 813 shares of Abiomed Inc worth $138K as of Q4 2019.
  • Advisor Group sold 2,308 Abiomed Inc shares in Q4 2019, an estimated $428K.
  • Abiomed Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2690 holding.
  • Advisor Group first reported a position in Abiomed Inc in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Abiomed Inc position peaked at $3.62M in Q3 2018.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.